Portfolio Holdings Detail for ISIN IE00BYXG2H39
Stock Name / Fund iShares Nasdaq US Biotechnology UCITS ETF USD (Acc)
Issuer Blackrock
Entity holding fund iShares IV Public Limited Company
Entity Type Umbrella investment company with variable capital and having segregated liability between its funds
Entity LEI 549300ZP07LMR36K1T02
ETF Ticker BTEC(USD) LSE
ETF Ticker BTEK(GBP) LSE
ETF Ticker 2B70(EUR) F
ETF Ticker 2B70.DE(EUR) CXE
ETF Ticker BTEC.LS(USD) CXE
ETF Ticker BTEK.LS(GBP) CXE
ETF Ticker BTEC.L(GBP) LSE
ETF Ticker BTEK.L(GBP) LSE

Holdings detail for VCYT

Stock Name	Veracyte Inc
Ticker	VCYT(USD) NASDAQ
TYPE	Common Stock
Country	USA
ISIN	US92337F1075
LEI	529900ESWZRHXOW27Z37

Show aggregate VCYT holdings

News associated with VCYT

1,616 Shares in Veracyte, Inc. (NASDAQ:VCYT) Purchased by Headlands Technologies LLC: Headlands Technologies LLC purchased a new position in shares of Veracyte, Inc. (NASDAQ:VCYT – Free Report) in the 1st quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor purchased 1,616 shares of the biotechnology company’s stock, valued at approximately $48,000. Several other large investors have also […] - 2025-08-13 05:22:59
Veracyte, Inc. (NASDAQ:VCYT) Given Consensus Recommendation of “Moderate Buy” by Brokerages: Shares of Veracyte, Inc. (NASDAQ:VCYT – Get Free Report) have earned a consensus rating of “Moderate Buy” from the ten research firms that are covering the firm, MarketBeat Ratings reports. One research analyst has rated the stock with a sell rating, one has given a hold rating and eight have issued a buy rating on […] - 2025-08-12 02:44:59
Veracyte, Inc. (NASDAQ:VCYT) Shares Purchased by Zurcher Kantonalbank Zurich Cantonalbank: Zurcher Kantonalbank Zurich Cantonalbank increased its position in shares of Veracyte, Inc. (NASDAQ:VCYT – Free Report) by 12.2% in the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 29,368 shares of the biotechnology company’s stock after purchasing an additional 3,201 shares during the […] - 2025-08-06 04:52:59
Veracyte (NASDAQ:VCYT) Stock Acquired Rep. Gilbert Ray Cisneros, Jr.: Representative Gilbert Ray Cisneros, Jr. (D-California) recently bought shares of Veracyte, Inc. (NASDAQ:VCYT). In a filing disclosed on July 10th, the Representative disclosed that they had bought between $1,001 and $15,000 in Veracyte stock on June 16th. The trade occurred in the Representative’s “150 MAIN STREET TRUST > BANK OF AMERICA” account. Representative Gilbert Ray […] - 2025-07-28 03:00:42
Veracyte, Inc. (NASDAQ:VCYT) Shares Sold by Bank Julius Baer & Co. Ltd Zurich: Bank Julius Baer & Co. Ltd Zurich reduced its stake in Veracyte, Inc. (NASDAQ:VCYT – Free Report) by 9.8% during the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 18,905 shares of the biotechnology company’s stock after selling 2,059 shares during the period. […] - 2025-07-25 06:31:01
Brokerages Set Veracyte, Inc. (NASDAQ:VCYT) Price Target at $40.90: Shares of Veracyte, Inc. (NASDAQ:VCYT – Get Free Report) have been assigned an average rating of “Moderate Buy” from the ten brokerages that are currently covering the stock, Marketbeat.com reports. One research analyst has rated the stock with a sell rating, one has issued a hold rating and eight have assigned a buy rating to […] - 2025-07-21 02:14:56
Veracyte, Inc. (NASDAQ:VCYT) Shares Sold by Teacher Retirement System of Texas: Teacher Retirement System of Texas lowered its stake in Veracyte, Inc. (NASDAQ:VCYT – Free Report) by 49.3% during the first quarter, HoldingsChannel reports. The institutional investor owned 33,938 shares of the biotechnology company’s stock after selling 33,036 shares during the quarter. Teacher Retirement System of Texas’ holdings in Veracyte were worth $1,006,000 at the end […] - 2025-07-14 04:50:48
Veracyte, Inc. (NASDAQ:VCYT) Shares Sold by Diversified Trust Co: Diversified Trust Co lowered its stake in shares of Veracyte, Inc. (NASDAQ:VCYT – Free Report) by 48.1% in the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 8,840 shares of the biotechnology company’s stock after selling 8,209 shares during the quarter. Diversified Trust Co’s holdings […] - 2025-07-02 05:18:56
Veracyte, Inc. (NASDAQ:VCYT) Receives $40.90 Average Target Price from Analysts: Veracyte, Inc. (NASDAQ:VCYT – Get Free Report) has been assigned a consensus rating of “Moderate Buy” from the ten analysts that are currently covering the stock, MarketBeat Ratings reports. One investment analyst has rated the stock with a sell recommendation, one has issued a hold recommendation and eight have assigned a buy recommendation to the […] - 2025-06-26 02:23:05
Exchange Traded Concepts LLC Increases Stake in Veracyte, Inc. (NASDAQ:VCYT): Exchange Traded Concepts LLC boosted its holdings in Veracyte, Inc. (NASDAQ:VCYT – Free Report) by 32.5% during the 1st quarter, according to its most recent disclosure with the SEC. The firm owned 91,994 shares of the biotechnology company’s stock after buying an additional 22,565 shares during the period. Exchange Traded Concepts LLC owned approximately 0.12% […] - 2025-06-17 05:36:53
Rhumbline Advisers Sells 2,870 Shares of Veracyte, Inc. (NASDAQ:VCYT): Rhumbline Advisers cut its holdings in Veracyte, Inc. (NASDAQ:VCYT – Free Report) by 2.3% during the first quarter, according to its most recent Form 13F filing with the SEC. The firm owned 120,454 shares of the biotechnology company’s stock after selling 2,870 shares during the period. Rhumbline Advisers’ holdings in Veracyte were worth $3,571,000 as […] - 2025-06-15 06:08:55
California State Teachers Retirement System Sells 510 Shares of Veracyte, Inc. (NASDAQ:VCYT): California State Teachers Retirement System lowered its holdings in shares of Veracyte, Inc. (NASDAQ:VCYT – Free Report) by 0.7% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 71,834 shares of the biotechnology company’s stock after selling 510 shares during the […] - 2025-06-06 06:02:58
Janus Henderson Group PLC Acquires 4,000 Shares of Veracyte, Inc. (NASDAQ:VCYT): Janus Henderson Group PLC raised its holdings in Veracyte, Inc. (NASDAQ:VCYT – Free Report) by 13.2% in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 34,326 shares of the biotechnology company’s stock after acquiring an additional 4,000 shares during the quarter. Janus Henderson […] - 2025-05-23 05:27:01
Deutsche Bank AG Purchases 24,197 Shares of Veracyte, Inc. (NASDAQ:VCYT): Deutsche Bank AG grew its position in Veracyte, Inc. (NASDAQ:VCYT – Free Report) by 42.4% in the fourth quarter, Holdings Channel reports. The fund owned 81,266 shares of the biotechnology company’s stock after acquiring an additional 24,197 shares during the quarter. Deutsche Bank AG’s holdings in Veracyte were worth $3,218,000 at the end of the […] - 2025-05-21 04:42:57
The Manufacturers Life Insurance Company Sells 1,731 Shares of Veracyte, Inc. (NASDAQ:VCYT): The Manufacturers Life Insurance Company lessened its stake in Veracyte, Inc. (NASDAQ:VCYT – Free Report) by 4.1% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 40,186 shares of the biotechnology company’s stock after selling 1,731 shares during the quarter. The Manufacturers Life Insurance Company […] - 2025-05-12 04:43:01
Tudor Investment Corp ET AL Sells 20,531 Shares of Veracyte, Inc. (NASDAQ:VCYT): Tudor Investment Corp ET AL lessened its holdings in Veracyte, Inc. (NASDAQ:VCYT – Free Report) by 50.2% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 20,342 shares of the biotechnology company’s stock after selling 20,531 shares during the quarter. […] - 2025-05-08 06:44:55
Veracyte, Inc. (NASDAQ:VCYT) Shares Bought by Hsbc Holdings PLC: Hsbc Holdings PLC grew its stake in Veracyte, Inc. (NASDAQ:VCYT – Free Report) by 14.5% in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 11,084 shares of the biotechnology company’s stock after acquiring an additional 1,406 shares during the quarter. Hsbc Holdings PLC’s holdings […] - 2025-05-08 06:07:00
Price T Rowe Associates Inc. MD Has $1.92 Million Holdings in Veracyte, Inc. (NASDAQ:VCYT): Price T Rowe Associates Inc. MD raised its stake in Veracyte, Inc. (NASDAQ:VCYT – Free Report) by 3.9% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 48,414 shares of the biotechnology company’s stock after acquiring an additional 1,816 shares during the quarter. […] - 2025-05-08 04:58:52
Voya Investment Management LLC Decreases Position in Veracyte, Inc. (NASDAQ:VCYT): Voya Investment Management LLC decreased its position in Veracyte, Inc. (NASDAQ:VCYT – Free Report) by 7.2% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 23,066 shares of the biotechnology company’s stock after selling 1,781 shares during the period. Voya Investment Management […] - 2025-05-07 05:58:57
Brokerages Set Veracyte, Inc. (NASDAQ:VCYT) PT at $42.60: Veracyte, Inc. (NASDAQ:VCYT – Get Free Report) has been assigned a consensus rating of “Moderate Buy” from the ten ratings firms that are currently covering the stock, MarketBeat reports. One investment analyst has rated the stock with a sell recommendation, one has given a hold recommendation and eight have assigned a buy recommendation to the […] - 2025-05-07 02:19:08
Veracyte, Inc. (NASDAQ:VCYT) Short Interest Up 22.5% in April: Veracyte, Inc. (NASDAQ:VCYT – Get Free Report) was the recipient of a significant growth in short interest in April. As of April 15th, there was short interest totalling 5,110,000 shares, a growth of 22.5% from the March 31st total of 4,170,000 shares. Based on an average daily volume of 956,000 shares, the short-interest ratio is […] - 2025-05-05 02:36:53
First Trust Advisors LP Has $8.08 Million Stock Holdings in Veracyte, Inc. (NASDAQ:VCYT): First Trust Advisors LP boosted its position in Veracyte, Inc. (NASDAQ:VCYT – Free Report) by 155.8% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 204,042 shares of the biotechnology company’s stock after acquiring an additional 124,275 shares during the quarter. First Trust Advisors […] - 2025-04-30 05:52:59
Russell Investments Group Ltd. Has $2.60 Million Stock Holdings in Veracyte, Inc. (NASDAQ:VCYT): Russell Investments Group Ltd. increased its position in shares of Veracyte, Inc. (NASDAQ:VCYT – Free Report) by 233.3% in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 65,541 shares of the biotechnology company’s stock after purchasing an additional 45,876 shares during the quarter. […] - 2025-04-18 04:53:09
Veracyte, Inc. (NASDAQ:VCYT) Shares Bought by Alliancebernstein L.P.: Alliancebernstein L.P. grew its stake in Veracyte, Inc. (NASDAQ:VCYT – Free Report) by 2.1% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 98,420 shares of the biotechnology company’s stock after purchasing an additional 2,000 shares during the period. Alliancebernstein L.P. owned […] - 2025-04-15 04:52:54
Veracyte (NASDAQ:VCYT) Given New $37.00 Price Target at Guggenheim: Veracyte (NASDAQ:VCYT – Get Free Report) had its price objective cut by stock analysts at Guggenheim from $45.00 to $37.00 in a research report issued on Wednesday,Benzinga reports. The firm currently has a “buy” rating on the biotechnology company’s stock. Guggenheim’s price objective points to a potential upside of 22.31% from the stock’s current price. […] - 2025-04-11 04:46:55
Veracyte (NASDAQ:VCYT) Shares Gap Down After Analyst Downgrade: Shares of Veracyte, Inc. (NASDAQ:VCYT – Get Free Report) gapped down before the market opened on Wednesday after Guggenheim lowered their price target on the stock from $45.00 to $37.00. The stock had previously closed at $28.88, but opened at $27.22. Guggenheim currently has a buy rating on the stock. Veracyte shares last traded at […] - 2025-04-10 02:40:48
Norges Bank Takes $8.93 Million Position in Veracyte, Inc. (NASDAQ:VCYT): Norges Bank acquired a new position in Veracyte, Inc. (NASDAQ:VCYT – Free Report) in the fourth quarter, Holdings Channel reports. The firm acquired 225,602 shares of the biotechnology company’s stock, valued at approximately $8,934,000. A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in VCYT. […] - 2025-04-09 04:56:52
Veracyte, Inc. (NASDAQ:VCYT) Shares Acquired by Vanguard Group Inc.: Vanguard Group Inc. increased its position in Veracyte, Inc. (NASDAQ:VCYT – Free Report) by 6.0% in the 4th quarter, Holdings Channel.com reports. The firm owned 8,211,612 shares of the biotechnology company’s stock after buying an additional 463,098 shares during the quarter. Vanguard Group Inc. owned about 0.11% of Veracyte worth $325,180,000 as of its most […] - 2025-04-04 05:04:58
Corebridge Financial Inc. Lowers Stake in Veracyte, Inc. (NASDAQ:VCYT): Corebridge Financial Inc. decreased its position in shares of Veracyte, Inc. (NASDAQ:VCYT – Free Report) by 7.0% during the 4th quarter, HoldingsChannel.com reports. The institutional investor owned 38,204 shares of the biotechnology company’s stock after selling 2,885 shares during the quarter. Corebridge Financial Inc.’s holdings in Veracyte were worth $1,513,000 at the end of the […] - 2025-04-03 05:49:01
Prudential Financial Inc. Has $4.83 Million Stake in Veracyte, Inc. (NASDAQ:VCYT): Prudential Financial Inc. raised its position in shares of Veracyte, Inc. (NASDAQ:VCYT – Free Report) by 602.6% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 122,003 shares of the biotechnology company’s stock after acquiring an additional 104,639 shares during the period. […] - 2025-04-01 05:32:46

iShares Nasdaq US Biotechnology UCITS ETF USD (Acc) VCYT holdings

Date	Number of VCYT Shares Held	Base Market Value of VCYT Shares	Local Market Value of VCYT Shares	Change in VCYT Shares Held	Change in VCYT Base Value	Current Price per VCYT Share Held	Previous Price per VCYT Share Held
2025-12-03 (Wednesday)	55,732	USD 2,661,203	USD 2,661,203	0	USD 88,614	USD 47.75	USD 46.16
2025-12-02 (Tuesday)	55,732	USD 2,572,589	USD 2,572,589	1,980	USD 79,034	USD 46.16	USD 46.39
2025-12-01 (Monday)	53,752	USD 2,493,555	USD 2,493,555	0	USD -51,065	USD 46.39	USD 47.34
2025-11-28 (Friday)	53,752	USD 2,544,620	USD 2,544,620	132	USD -13,590	USD 47.34	USD 47.71
2025-11-27 (Thursday)	53,620	USD 2,558,210	USD 2,558,210	0	USD 0	USD 47.71	USD 47.71
2025-11-26 (Wednesday)	53,620	USD 2,558,210	USD 2,558,210	396	USD -69,991	USD 47.71	USD 49.38
2025-11-25 (Tuesday)	53,224	USD 2,628,201	USD 2,628,201	660	USD 173,462	USD 49.38	USD 46.7
2025-11-24 (Monday)	52,564	USD 2,454,739	USD 2,454,739	132	USD 147,207	USD 46.7	USD 44.01
2025-11-21 (Friday)	52,432	USD 2,307,532	USD 2,307,532	0	USD 165,685	USD 44.01	USD 40.85
2025-11-20 (Thursday)	52,432	USD 2,141,847	USD 2,141,847	-528	USD 27,154	USD 40.85	USD 39.93
2025-11-19 (Wednesday)	52,960	USD 2,114,693	USD 2,114,693	132	USD 67,080	USD 39.93	USD 38.76
2025-11-18 (Tuesday)	52,828	USD 2,047,613	USD 2,047,613	792	USD 3,639	USD 38.76	USD 39.28
2025-11-17 (Monday)	52,036	USD 2,043,974	USD 2,043,974	264	USD 6,746	USD 39.28	USD 39.35

Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of VCYT by Blackrock for IE00BYXG2H39

Show aggregate share trades of VCYT

Date Action Quantity Market High Market Low Likely Trade Price Likely Trade Value (Profit/Loss) Average Price previous trades
2025-12-02 BUY 1,980 46.160* 34.06
2025-11-28 BUY 132 47.340* 33.94
2025-11-26 BUY 396 47.710* 33.81
2025-11-25 BUY 660 49.380* 33.73
2025-11-24 BUY 132 46.700* 33.67
2025-11-20 SELL -528 40.850* 33.59 Profit of 17,734 on sale
2025-11-19 BUY 132 39.930* 33.56
2025-11-18 BUY 792 38.760* 33.53
2025-11-17 BUY 264 39.280* 33.50
2025-11-14 BUY 132 39.350* 33.47
2025-11-12 BUY 132 42.300* 33.40
2025-11-10 BUY 132 42.350* 33.30
2025-11-06 BUY 132 41.690* 33.22
2025-11-04 BUY 132 36.120* 33.14
2025-10-30 BUY 660 36.140 35.180 35.276 USD 23,282 33.09
2025-10-29 BUY 1,275 35.410 36.365 36.270 USD 46,244 33.08
2025-10-22 SELL -516 34.750 36.253 36.103 USD -18,629 33.01 Loss of -1,596 on sale
2025-10-20 BUY 258 36.650 37.070 37.028 USD 9,553 32.97
2025-10-17 BUY 645 35.830 36.440 36.379 USD 23,464 32.96
2025-10-15 BUY 1,032 34.780 35.380 35.320 USD 36,450 32.95
2025-10-03 BUY 910 36.000 36.850 36.765 USD 33,456 32.92
2025-10-02 BUY 130 35.630 36.710 36.602 USD 4,758 32.91
2025-09-30 BUY 260 34.330 34.770 34.726 USD 9,029 32.88
2025-09-26 BUY 260 33.440 33.510 33.503 USD 8,711 32.88
2025-09-25 BUY 260 32.820 33.140 33.108 USD 8,608 32.88
2025-09-24 SELL -1,560 32.680 34.142 33.996 USD -53,033 32.88 Loss of -1,746 on sale
2025-09-18 BUY 134 33.230 33.380 33.365 USD 4,471 32.87
2025-09-17 BUY 405 31.830 33.020 32.901 USD 13,325 32.88
2025-08-20 SELL -536 29.490 29.676 29.657 USD -15,896 32.94 Profit of 1,760 on sale
2025-07-30 BUY 536 23.970 24.690 24.618 USD 13,195 33.14
2025-07-17 SELL -268 24.220 25.240 25.138 USD -6,737 33.67 Profit of 2,288 on sale
2025-07-11 SELL -1,072 27.080 27.752 27.685 USD -29,678 33.88 Profit of 6,644 on sale
2025-07-07 BUY 402 26.340 27.750 27.609 USD 11,099 34.08
2025-07-02 BUY 7,370 27.580 27.770 27.751 USD 204,525 34.17
2025-06-20 BUY 1,144 26.390 27.280 27.191 USD 31,107 34.23
2025-06-11 BUY 262 27.930 28.430 28.380 USD 7,436 34.61
2025-06-10 BUY 262 27.880 28.410 28.357 USD 7,430 34.66
2025-06-04 SELL -131 27.290 27.430 27.416 USD -3,591 34.89 Profit of 979 on sale
2025-04-23 BUY 130 31.465 32.840 32.703 USD 4,251 36.61
2025-04-10 SELL -1,040 30.250 31.605 31.469 USD -32,728 37.15 Profit of 5,911 on sale
2025-04-08 SELL -130 28.880 30.970 30.761 USD -3,999 37.30 Profit of 850 on sale
2025-04-07 SELL -130 29.530 30.800 30.673 USD -3,987 37.39 Profit of 873 on sale
2025-04-04 SELL -650 28.950 29.430 29.382 USD -19,098 37.49 Profit of 5,271 on sale
2025-04-01 BUY 1,303 29.560 30.535 30.437 USD 39,660 37.67
2025-03-31 SELL -384 29.650 30.160 30.109 USD -11,562 37.77 Profit of 2,943 on sale
2025-03-21 BUY 1,889 31.820 32.050 32.027 USD 60,499 38.24
2025-03-14 SELL -1,952 31.510 31.900 31.861 USD -62,193 38.72 Profit of 13,380 on sale
2025-03-07 SELL -244 32.020 32.670 32.605 USD -7,956 39.30 Profit of 1,634 on sale
2025-03-04 SELL -122 34.110 34.430 34.398 USD -4,197 39.59 Profit of 634 on sale
2025-02-25 BUY 244 33.460 38.785 38.252 USD 9,334 40.05
2025-02-19 SELL -121 42.110 42.260 42.245 USD -5,112 40.03 Loss of -268 on sale
2025-02-13 BUY 363 39.590 41.030 40.886 USD 14,842 39.99
2025-02-12 BUY 121 40.380 41.180 41.100 USD 4,973 39.98
2025-02-11 BUY 484 40.970 42.000 41.897 USD 20,278 39.96
2024-12-30 SELL -3,734 40.000 40.447 40.402 USD -150,862 38.36 Loss of -7,620 on sale
2024-11-18 SELL -1,965 36.710 37.300 37.241 USD -73,179 34.69 Loss of -5,007 on sale
2024-11-08 SELL -131 36.480 37.840 37.704 USD -4,939 34.31 Loss of -444 on sale
2024-10-21 SELL -132 33.120 34.440 34.308 USD -4,529 0.00 Loss of -4,529 on sale
Market high and low price is on the date.

Date	Action	Quantity	Market High	Market Low	Likely Trade Price	Likely Trade Value (Profit/Loss)	Average Price previous trades
2025-12-02	BUY	1,980			46.160*		34.06
2025-11-28	BUY	132			47.340*		33.94
2025-11-26	BUY	396			47.710*		33.81
2025-11-25	BUY	660			49.380*		33.73
2025-11-24	BUY	132			46.700*		33.67
2025-11-20	SELL	-528			40.850*		33.59 Profit of 17,734 on sale
2025-11-19	BUY	132			39.930*		33.56
2025-11-18	BUY	792			38.760*		33.53
2025-11-17	BUY	264			39.280*		33.50
2025-11-14	BUY	132			39.350*		33.47
2025-11-12	BUY	132			42.300*		33.40
2025-11-10	BUY	132			42.350*		33.30
2025-11-06	BUY	132			41.690*		33.22
2025-11-04	BUY	132			36.120*		33.14
2025-10-30	BUY	660	36.140	35.180	35.276	USD 23,282	33.09
2025-10-29	BUY	1,275	35.410	36.365	36.270	USD 46,244	33.08
2025-10-22	SELL	-516	34.750	36.253	36.103	USD -18,629	33.01 Loss of -1,596 on sale
2025-10-20	BUY	258	36.650	37.070	37.028	USD 9,553	32.97
2025-10-17	BUY	645	35.830	36.440	36.379	USD 23,464	32.96
2025-10-15	BUY	1,032	34.780	35.380	35.320	USD 36,450	32.95
2025-10-03	BUY	910	36.000	36.850	36.765	USD 33,456	32.92
2025-10-02	BUY	130	35.630	36.710	36.602	USD 4,758	32.91
2025-09-30	BUY	260	34.330	34.770	34.726	USD 9,029	32.88
2025-09-26	BUY	260	33.440	33.510	33.503	USD 8,711	32.88
2025-09-25	BUY	260	32.820	33.140	33.108	USD 8,608	32.88
2025-09-24	SELL	-1,560	32.680	34.142	33.996	USD -53,033	32.88 Loss of -1,746 on sale
2025-09-18	BUY	134	33.230	33.380	33.365	USD 4,471	32.87
2025-09-17	BUY	405	31.830	33.020	32.901	USD 13,325	32.88
2025-08-20	SELL	-536	29.490	29.676	29.657	USD -15,896	32.94 Profit of 1,760 on sale
2025-07-30	BUY	536	23.970	24.690	24.618	USD 13,195	33.14
2025-07-17	SELL	-268	24.220	25.240	25.138	USD -6,737	33.67 Profit of 2,288 on sale
2025-07-11	SELL	-1,072	27.080	27.752	27.685	USD -29,678	33.88 Profit of 6,644 on sale
2025-07-07	BUY	402	26.340	27.750	27.609	USD 11,099	34.08
2025-07-02	BUY	7,370	27.580	27.770	27.751	USD 204,525	34.17
2025-06-20	BUY	1,144	26.390	27.280	27.191	USD 31,107	34.23
2025-06-11	BUY	262	27.930	28.430	28.380	USD 7,436	34.61
2025-06-10	BUY	262	27.880	28.410	28.357	USD 7,430	34.66
2025-06-04	SELL	-131	27.290	27.430	27.416	USD -3,591	34.89 Profit of 979 on sale
2025-04-23	BUY	130	31.465	32.840	32.703	USD 4,251	36.61
2025-04-10	SELL	-1,040	30.250	31.605	31.469	USD -32,728	37.15 Profit of 5,911 on sale
2025-04-08	SELL	-130	28.880	30.970	30.761	USD -3,999	37.30 Profit of 850 on sale
2025-04-07	SELL	-130	29.530	30.800	30.673	USD -3,987	37.39 Profit of 873 on sale
2025-04-04	SELL	-650	28.950	29.430	29.382	USD -19,098	37.49 Profit of 5,271 on sale
2025-04-01	BUY	1,303	29.560	30.535	30.437	USD 39,660	37.67
2025-03-31	SELL	-384	29.650	30.160	30.109	USD -11,562	37.77 Profit of 2,943 on sale
2025-03-21	BUY	1,889	31.820	32.050	32.027	USD 60,499	38.24
2025-03-14	SELL	-1,952	31.510	31.900	31.861	USD -62,193	38.72 Profit of 13,380 on sale
2025-03-07	SELL	-244	32.020	32.670	32.605	USD -7,956	39.30 Profit of 1,634 on sale
2025-03-04	SELL	-122	34.110	34.430	34.398	USD -4,197	39.59 Profit of 634 on sale
2025-02-25	BUY	244	33.460	38.785	38.252	USD 9,334	40.05
2025-02-19	SELL	-121	42.110	42.260	42.245	USD -5,112	40.03 Loss of -268 on sale
2025-02-13	BUY	363	39.590	41.030	40.886	USD 14,842	39.99
2025-02-12	BUY	121	40.380	41.180	41.100	USD 4,973	39.98
2025-02-11	BUY	484	40.970	42.000	41.897	USD 20,278	39.96
2024-12-30	SELL	-3,734	40.000	40.447	40.402	USD -150,862	38.36 Loss of -7,620 on sale
2024-11-18	SELL	-1,965	36.710	37.300	37.241	USD -73,179	34.69 Loss of -5,007 on sale
2024-11-08	SELL	-131	36.480	37.840	37.704	USD -4,939	34.31 Loss of -444 on sale
2024-10-21	SELL	-132	33.120	34.440	34.308	USD -4,529	0.00 Loss of -4,529 on sale

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of VCYT

Date	Shorted Volume	Short Exempt Volume	Total Shares Traded	% Shorted
2025-09-19	402,884	350	744,518	54.1%
2025-09-18	133,694	0	302,246	44.2%
2025-09-17	102,785	125	273,625	37.6%
2025-09-16	87,040	0	147,745	58.9%
2025-09-15	132,517	56	260,101	50.9%
2025-09-12	104,528	0	208,625	50.1%
2025-09-11	145,462	0	339,206	42.9%
2025-09-10	375,703	0	425,984	88.2%
2025-09-09	166,026	0	264,898	62.7%
2025-09-08	308,588	0	416,299	74.1%
2025-09-05	304,507	10,500	433,106	70.3%
2025-09-04	285,198	9,691	351,707	81.1%
2025-09-03	290,774	0	410,275	70.9%
2025-09-02	242,677	328	272,947	88.9%
2025-08-29	221,159	98	280,820	78.8%
2025-08-28	175,074	2	379,194	46.2%
2025-08-27	232,979	0	412,237	56.5%
2025-08-26	109,763	0	254,603	43.1%
2025-08-25	126,935	150	195,395	65.0%
2025-08-22	178,073	0	354,773	50.2%
2025-08-21	181,726	8,870	254,596	71.4%
2025-08-20	138,840	313	198,829	69.8%
2025-08-19	153,214	124	248,803	61.6%
2025-08-18	106,906	2,453	169,688	63.0%
2025-08-15	178,920	3,513	228,774	78.2%
2025-08-14	322,958	483	432,341	74.7%
2025-08-13	669,266	26	854,665	78.3%
2025-08-12	356,389	699	440,945	80.8%
2025-08-11	355,148	650	511,010	69.5%
2025-08-08	457,220	700	602,613	75.9%
2025-08-07	583,576	120	1,202,651	48.5%
2025-08-06	313,073	96	542,796	57.7%
2025-08-05	399,687	16	494,592	80.8%
2025-08-04	291,020	107	420,209	69.3%
2025-08-01	239,653	10	322,446	74.3%
2025-07-31	311,916	3,467	452,665	68.9%
2025-07-30	406,408	1,200	573,800	70.8%
2025-07-29	514,194	14	682,098	75.4%
2025-07-28	1,469,060	160	2,707,100	54.3%
2025-07-25	980,574	16,828	2,309,758	42.5%
2025-07-24	70,902	139	182,759	38.8%
2025-07-23	114,868	377	213,735	53.7%
2025-07-22	131,718	134	372,351	35.4%
2025-07-21	94,278	3,694	206,207	45.7%
2025-07-18	151,324	1,062	447,377	33.8%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Note: All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability.

Stock Name / Fund	iShares Nasdaq US Biotechnology UCITS ETF USD (Acc)
Issuer	Blackrock
Entity holding fund	iShares IV Public Limited Company
Entity Type	Umbrella investment company with variable capital and having segregated liability between its funds
Entity LEI	549300ZP07LMR36K1T02
ETF Ticker	BTEC(USD) LSE
ETF Ticker	BTEK(GBP) LSE
ETF Ticker	2B70(EUR) F
ETF Ticker	2B70.DE(EUR) CXE
ETF Ticker	BTEC.LS(USD) CXE
ETF Ticker	BTEK.LS(GBP) CXE
ETF Ticker	BTEC.L(GBP) LSE
ETF Ticker	BTEK.L(GBP) LSE